Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis

Volume: 71, Pages: 103567 - 103567
Published: Sep 1, 2021
Abstract
During the course of the SARS-CoV-2 pandemic, patients established on in-centre maintenance haemodialysis found themselves in a unique and unenviable predicament: deemed to be clinically extremely vulnerable to COVID-19 by virtue of their end stage kidney disease (ESKD), and yet unable to shield due to their need to regularly access a life-sustaining therapy in a healthcare setting. Renal healthcare providers around the world did their best to...
Paper Details
Title
Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis
Published Date
Sep 1, 2021
Volume
71
Pages
103567 - 103567
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.